Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acyclovir.

T M Appelboom, F P Flowers

    Southern Medical Journal
    |July 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Acyclovir is a new antiviral medication effective against herpes simplex virus (HSV) and other herpes-group viruses. While generally safe and effective, research is ongoing to address potential renal toxicity and viral resistance.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pancreatic panniculitis.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2005
    Same author

    Distant cancer effects on standardised testing of peripheral vision.

    The British journal of ophthalmology·2001
    Same author

    Persistent verrucous varicella as the initial manifestation of HIV infection.

    Journal of the American Academy of Dermatology·2001
    Same author

    Asymptomatic eyelid papule in a 57-year-old healthy man.

    Archives of dermatology·2000
    Same author

    Treatment of tinea nigra with terbinafine.

    Cutis·1999
    Same author

    Skin cancer of the head and neck with incidental microscopic perineural invasion.

    International journal of radiation oncology, biology, physics·1999
    Same journal

    The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

    Southern medical journal·2026
    Same journal

    α-Gal Syndrome in the South: Why We Need Treatment Trials, Not Just Tick Prevention.

    Southern medical journal·2026
    Same journal

    Association between Main Pancreatic Duct Size, Comorbidities, and Fistula Formation after Whipple Procedure for Pancreatic Cancer.

    Southern medical journal·2026
    Same journal

    Impact of Temperature Variation on Patients with Acute Severe Asthma.

    Southern medical journal·2026
    Same journal

    Assessing the Accuracy and Reliability of ChatGPT-4 to Answer Clinical EHR Messages in Sports Medicine.

    Southern medical journal·2026
    Same journal

    Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

    Southern medical journal·2026
    See all related articles

    Area of Science:

    • Virology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Herpes simplex virus (HSV) infections present a significant health challenge.
    • Effective antiviral treatments for HSV have been limited until recently.
    • Acyclovir represents a breakthrough in managing herpes-group viral infections.

    Purpose of the Study:

    • To introduce acyclovir as a novel antiviral agent.
    • To detail the mechanism of action and efficacy of acyclovir.
    • To discuss current research and challenges associated with acyclovir therapy.

    Main Methods:

    • Review of acyclovir's pharmacological properties.
    • Analysis of its selective action on virus-infected cells.
    • Examination of clinical data regarding efficacy and toxicity.

    Related Experiment Videos

    Main Results:

    • Acyclovir demonstrates broad-spectrum activity against herpes-group viruses.
    • The drug exhibits high efficacy and low toxicity due to preferential phosphorylation in viral cells.
    • Potential issues include renal toxicity and the development of viral resistance.

    Conclusions:

    • Acyclovir is the first effective drug approved for HSV treatment.
    • Ongoing research aims to further understand and optimize acyclovir's use.
    • Addressing renal toxicity and viral resistance is crucial for long-term therapeutic success.